or Try an Advanced Search...

    Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.85 -4.40% -0.09
    AMLX closed down 2.03 percent on Wednesday, May 8, 2024, on 38 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Down
    Historical AMLX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish -4.40%
    Spinning Top Other -4.40%
    Narrow Range Bar Range Contraction -4.40%
    Down 3 Days in a Row Weakness -4.40%
    20 DMA Resistance Bearish -6.35%
    Spinning Top Other -6.35%
    NR7 Range Contraction -6.35%
    NR7-2 Range Contraction -6.35%
    Narrow Range Bar Range Contraction -6.35%
    Wide Bands Range Expansion -6.35%
    Older End-of-Day Signals for AMLX ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 4 hours ago
    2x Volume Pace about 4 hours ago
    1.5x Volume Pace about 4 hours ago
    Fell Below Lower Bollinger Band about 4 hours ago
    Down 5% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AMLX Chart by TradingView
    Basic chart:

    Profile

    Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis Neurodegenerative Disease

    Is AMLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2024 Earnings Call Transcript
    May 9 Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
    May 9 Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M
    May 9 Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
    May 8 Amylyx Pharmaceuticals Q1 2024 Earnings Preview
    May 8 Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
    May 2 Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
    Apr 30 Trials to watch: Four ALS drugs to keep an eye on
    Apr 12 The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
    Apr 10 Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
    See more AMLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 30.5
    52 Week Low 1.7
    Average Volume 3,919,143
    200-Day Moving Average 14.12
    50-Day Moving Average 4.79
    20-Day Moving Average 1.96
    10-Day Moving Average 1.91
    Average True Range 0.24
    RSI (14) 28.06
    ADX 54.63
    +DI 14.13
    -DI 39.61
    Chandelier Exit (Long, 3 ATRs) 2.11
    Chandelier Exit (Short, 3 ATRs) 2.41
    Upper Bollinger Bands 2.19
    Lower Bollinger Band 1.73
    Percent B (%b) 0.43
    BandWidth 23.60
    MACD Line -0.68
    MACD Signal Line -0.94
    MACD Histogram 0.2603
    Fundamentals Value
    Market Cap 130.31 Million
    Num Shares 67.5 Million
    EPS 0.01
    Price-to-Earnings (P/E) Ratio 193.00
    Price-to-Sales 3.73
    Price-to-Book 2.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.08
    Resistance 3 (R3) 2.08 2.04 2.06
    Resistance 2 (R2) 2.04 2.00 2.04 2.05
    Resistance 1 (R1) 1.98 1.97 1.96 1.98 2.04
    Pivot Point 1.94 1.94 1.93 1.94 1.94
    Support 1 (S1) 1.88 1.90 1.86 1.88 1.82
    Support 2 (S2) 1.84 1.87 1.84 1.81
    Support 3 (S3) 1.78 1.84 1.81
    Support 4 (S4) 1.78